The global biofilms treatment market is growing at a significant CAGR of around 7.3% during the forecast period (2019-2025). Biofilms are found in majority of chronic wounds, such as diabetic foot ulcers, and other chronic skin wounds. The major factors that are primarily driving the growth of the market include the increasing prevalence of diabetes and high incidence of obesity due to sedentary lifestyle and unhealthy dietary habits. According to the International Diabetes Federation (IDF), the prevalence of diabetes across the globe is expected to reach 642 million in 2040, up from 415 million in 2015. The rapidly growing prevalence of diabetes accounted for around 12% of the global healthcare expenditure, around $673 billion in 2015, and this expenditure is projected to reach $802 billion by 2040. According to the American Podiatric Medical Association (APMA), diabetic foot ulcer is a wound or open sore that occurs in nearly 15% of diabetic patients and is usually located on the bottom of the foot. Therefore, such large prevalence of diabetic food ulcers augments the need for biofilms, in order to tackle the disease with an effective assault. 

Moreover, the rising number of surgeries for accidental injuries raises the demand for biofilms treatment. There were 17.5 million surgical and minimally invasive cosmetic procedures performed in the US in 2017, according to the American Society of Plastic Surgeons (ASPS). In addition, the rising number of burn surgeries are further contributing in the market growth. According to the World Health Organization (WHO), an estimated 180,000 deaths occur annually from fires alone. 95% of fatal fire-related occurs in middle- and low-income countries. This increases the demand for biofilm treatment, as the formation of biofilm delays the wound healing. Therefore, biofilms treatment is required to heal the burns, which in turn, increases its demand in burn surgeries. However, the high cost and lack of awareness of advanced wound products restraints the market growth across the globe.

Segmental Outlook  

The biofilms treatment market is classified on the basis of product type, wound type, and end-user. Based on product type, the market is segmented into debridement equipment, gauze, dressing, gel, and others. Based on wound type, the market is classified into traumatic, surgical, diabetic foot ulcers, and others. Based on end-user, the market is segmented into homecare, hospitals and clinics, ambulatory surgical centers, and others.

Global Biofilms Treatment Market Share by Wound Type, 2018 (%)

Biofilms treatment finds significant application in traumatic wounds

Traumatic wounds are one of the major application of biofilms treatment. The increasing number of road accident injuries is a major driving factor for biofilms treatment for traumatic wound. Road traffic accidents are the most common types of traumatic wounds. According to the World Health Organization (WHO), around 20 to 50 million people suffers from non-fatal injuries, with several incurring a disability as a result of their injury. These injuries forms biofilms, which delays the healing process. Therefore, the biofilms treatment is certainly requiring in the treatment of such traumatic injuries. 

Regional Outlook 

The global biofilms treatment market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the biofilms treatment market. The growth of the region is due to rising number of surgical procedures coupled with rising sports injury across the region. Moreover, increased number of burn centers and presence of major players, such as ConvaTec Inc. is further augmenting the market growth in the region. According to Stanford Children’s Health Organization, a total of approximately 30 million children and teen participates in any form of organized sports and among these, approximately 3.5 million injuries are reported each year. As with the increasing healthcare issues among young population of the US, a shift towards sports has been observed in the recent years. Therefore, with the shift, number of injuries are estimated to increase during the forecast period, thus, will increase the number of opportunities for the biofilms treatment market in the region. 

Global Biofilms Treatment Market Growth, by Region 2019-2025

Asia-Pacific is expected to propel with a considerable growth rate in the global market

Asia-Pacific is estimated to project a considerable CAGR in the global biofilms treatment market. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. The market in the region is largely driven by the surging aging population which increases the possible risk of diabetes and pressure ulcers among the population. Diabetes may cause patients to develop diabetic foot ulcers, which in turn, would require wound dressing for its treatment. According to the International Diabetes Federation (IDF), In 2019, an estimated 116 million adults in China were suffering from diabetes, which is putting the diabetic patients at risk of life-threatening complications. More than 65 million of these adults, are undiagnosed and, therefore, may be particularly at risk. Such projections for the high prevalence of diabetes is expected to drive the market growth in Asia-Pacific during the forecast period. 

Market Players Outlook

The key players in the biofilms treatment market are contributing significantly by providing advanced technology-based products and through expanding their geographical presence across the globe. The key players operating in the global biofilms treatment market include Smith & Nephew PLC, ConvaTec Inc., Coloplast Corp., Zimmer Biomet, Kane Biotech Inc., and B. Braun Melsungen AG. These market players adopt various strategies such as product launch, partnerships, collaborations, merger, and acquisitions to sustain a strong position in the market. For instance, in February 2020, Kane Biotech Inc. launched ‘silkstem’ anti-ich shampoo for dogs and cats that contains coactiv+, Kane’s patented anti-biofilm formulation. This launch is expected to prove an important milestone for the company, as it’s the second animal health product line of Kane. 

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global biofilms treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.